Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucose metabolism and tumour microenvironment in pancreatic cancer: A key link in cancer progression
Shi Dong, Wancheng Li, Xin Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12

Showing 12 citing articles:

Immunotherapy and the ovarian cancer microenvironment: Exploring potential strategies for enhanced treatment efficacy
Zhibin Wang, Xiu Zhang, Chao Fang, et al.
Immunology (2024) Vol. 173, Iss. 1, pp. 14-32
Closed Access | Times Cited: 5
β-lapachone suppresses carcinogenesis of cervical cancer via interaction with AKT1
Pan Du, Yue Li, Anna Han, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Metabolic Regulation of CAR-T Cell Function by Hypoxic Tumor
Tanmaya Pathak, Suman Kumar Ray, Sukhes Mukherjee
(2025), pp. 77-95
Closed Access
Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions
Dhana Sekhar Reddy Bandi, Sujith Sarvesh, Batoul Farran, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 71-72, pp. 26-39
Closed Access | Times Cited: 11
GSH-responsive degradable nanodrug for glucose metabolism intervention and induction of ferroptosis to enhance magnetothermal anti-tumor therapy
Zhen Liao, E Wen, Yi Feng
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Apolipoprotein E is a prognostic factor for pancreatic cancer and associates with immune infiltration
Bin Wu, Xiaodan Yang, Fei Chen, et al.
Cytokine (2024) Vol. 179, pp. 156628-156628
Closed Access | Times Cited: 3
Promising Therapeutic Approach in Pancreatic Cancer: Metabolism-Related Genes
Soohyun Choe, Woori Kwak, E. Kim, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 4, pp. 137-137
Open Access | Times Cited: 2
Extranodal lymphoma: pathogenesis, diagnosis and treatment
Hua Yang, Yang Xun, Chao Ke, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 6
Metabolism and structure of PDA as the target for new therapies: possibilities and limitations for nanotechnology
Adrianna Zygmunt, Jerzy Gubernator
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 6, pp. 845-865
Closed Access | Times Cited: 1
RBM47 promotes cell proliferation and immune evasion by upregulating PDIA6: a novel mechanism of pancreatic cancer progression
Yihui Ma, Enjie Liu, Huijie Fan, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
Metadichol induced differentiation of pancreatic ductal cells (PANC-1) into insulin-producing cells
P.R. Raghavan
Research Square (Research Square) (2023)
Open Access
Metadichol-induced differentiation of pancreatic ductal cells (PANC-1) into insulin-producing cells
P.R. Raghavan
Research Square (Research Square) (2023)
Open Access
Metadichol-Induced Differentiation of Pancreatic Ductal Cells (PANC-1) into Insulin-Producing Cells
Palayakotai R Raghavan
Medical Research Archives (2023) Vol. 11, Iss. 11
Open Access
Page 1

Scroll to top